leadf
logo-loader
viewOrthocell Ltd
(
ASX:OCC
)

Orthocell welcomes further Asian patent protection for CelGro collagen rope

Orthocell Ltd's (ASX:OCC) Paul Anderson speaks to Proactive following the news it's been granted patents for its CelGro® collagen rope in China and Hong Kong, bringing the number of countries it is patented in to five. The collagen rope product, part of the company’s CelGro® collagen scaffold platform technology, is designed to augment ligament repair surgeries such as anterior cruciate ligament (ACL) reconstruction.

Quick facts: Orthocell Ltd

Follow
ASX:OCC

Price: 0.51 AUD

Market Cap: $97.68 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Orthocell looks ahead to results from OrthoATI shoulder tendon study in Q4

Orthocell Ltd (ASX:OCC)'s Paul Anderson tells Proactive they've has passed a key milestone by completing the 12-month follow-up of the last patient treated in the Autologous Tenocyte Injection (OrthoATI®) rotator cuff tendon study. The RC study was designed to assess the effectiveness of...

3 weeks, 2 days ago

2 min read